Pacira BioSciences, Inc. — Director's Dealing 2011

Feb 2, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2011-02-02

Reporting Person: LONGENECKER JOHN P PHD (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.61	2020-09-02	Common Stock (7438)		Direct
Stock Option (Right to Buy)	$1.61	2020-09-02	Common Stock (4649)		Direct
Stock Option (Right to Buy)	$1.61	2020-09-02	Common Stock (4649)		Direct

Footnotes

F1: The option vests as to 75% of the option shares on September 2, 2010 and, as to the remaining 25% of the option shares, in successive equal monthly installments for the subsequent 12 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering.

F2: The option vests as to 25% of the option shares on September 2, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering.

F3: The option vests as to 50% of the option shares upon the first anniversary of the Issuer's initial public offering and as to the remaining 50% of the option shares upon the second anniversary of the Issuer's initial public offering. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering.